Previous studies have reported that PHGDH is frequently overexpressed in a number of different cancer types including breast cancer, NSCLC, and melanoma, due to gene amplification, transcription, or post-translational modification16–18,23–28. The gene discussed is PHGDH; the disease is non-small cell lung carcinoma.